Details
New companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
Heaviside Industries $60M Series BHeaviside Industries $28M Series ARanked by rounds participated in, from announcements in Jan 1, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
Heaviside Industries $60M Series BHeaviside Industries $28M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Entravel Group $7.5M Funding roundHYFIX Spatial Intelligence $15M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Beyang Therapeutics $30M Series AVITURE $100M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
FORM ENERGY $750M Series GActuate Energy Undisclosed UndisclosedNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Cytix $7M Series ABidScript $800K Pre-SeedNew companies 2 · Follow-on 0
Stages: Series A 2
Beyang Therapeutics $30M Series ACORE Biomedicine $21M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Palette €3M Pre-SeedOrigin $30M Series A+New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
DR. VIVIEN KARL Undisclosed SeedGardia €8.5M Series ANew companies 2 · Follow-on 0
Stages: Series B 2
Vaderis Therapeutics $152M Series BAltesa BioSciences $75M Series BNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Soctera $4M SeedKanvas Biosciences $48M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Series B 1
ApartmentIQ $25M Follow-on investmentVisitt $22M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Neros Technologies $250M Series CAlloy Therapeutics $40M Series ENew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
Zerolook CHF 1.5M Pre-seedArtificial Labs $45M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Silicon Data $30.5M Series ATrue Anomaly $650M Series DNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
DR. VIVIEN KARL Undisclosed SeedVisioLab $11M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Natural $30M Series AAmbrook $30M Series BNew companies 2 · Follow-on 0
Stages: Series B 2
Aureka Biotechnologies $100M Series BEvoken ~$300M Series B+New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Aureka Biotechnologies $100M Series BVivatides Therapeutics $54M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
Cambridge Aerospace $300M Series CStord $250M Series FNew companies 2 · Follow-on 0
Stages: Series B 2
Aureka Biotechnologies $100M Series BEPG $100M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Flagler Health $50M Series BThrone Science $10M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Plinq R$1.3M First funding roundPaper $34M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Factbird Undisclosed Strategic majority investmentSerpier €1.4M Undisclosed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.